Schott Pharma, a global leader in drug containment solutions and delivery systems, has announced the expansion of its Pharmaversity initiative with the launch of a dedicated Knowledge Hub. Established in 2020, Pharmaversity serves as an educational platform designed to equip pharmaceutical professionals, academics, and stakeholders with deep, technical insights into packaging innovation and emerging pharma trends.

The newly introduced Knowledge Hub features over 100 curated resources, offering essential information and expert perspectives on advanced drug containment and delivery systems. It includes detailed data on glass and polymer materials, their performance characteristics, and pharmaceutical applications. The content is tailored to support both ongoing professional development and project-specific learning.

Pharmaversity goes beyond just the Knowledge Hub. It comprises:

• Academy: A dynamic learning platform offering expert-led training sessions and live webinars focused on specialized topics in glass and polymer packaging.

• Events: Opportunities for in-person and virtual engagement at global conferences and industry gatherings across Europe, the Americas, and Asia.

By offering access to research, case studies, and interactive events, Schott Pharma’s Pharmaversity enables professionals—regardless of experience level—to deepen their understanding of critical aspects like primary packaging, materials science, and drug-device integration.

The platform is designed for those who may need specialized knowledge at specific stages of their careers or for unique project demands. All content is developed by Schott Pharma’s renowned team of glass and polymer experts, ensuring relevance, technical depth, and practical application.

As part of its mission to make healthcare safer and more effective, Schott Pharma continues to design science-based solutions used globally. Every minute, more than 25,000 injections are delivered using a Schott Pharma product—from prefillable syringes to cartridges, vials, and ampoules.